Skip to main content

Table 4 Comparison of clinical and biological characteristics between patients with and without osteoporosis

From: Mineral bone disorder and osteoporosis in hemodialysis patients

 NormalOsteopeniaOsteoporosisp
Age (years)
 Lumbar52.03 ± 14.1852.55 ± 14.2665.87 ± 10.070.034
 Total hip49.58 ± 15.0251.71 ± 12.8663.94 ± 11.390.001
 All50.06 ± 15.0950.42 ± 13.5063.94 ± 11.390.001
Age of onset of HD (years)
 Lumbar49.33 ± 14.4249.03 ± 14.5763.37 ± 10.020.031
 Total hip50.06 ± 15.0948.84 ± 13.5860.5 ± 11.640.001
 All46.87 ± 14.7148.21 ± 14.1663.85 ± 14.82<  10-3
PTH (pg/mL)
 Lumbar410.67 ± 402.97496.15 ± 385.55430.16 ± 383.980.425
 Total hip265.87 ± 237.20518.56 ± 420.46512.46 ± 426.620.013
 All249.01 ± 217.38516.89 ± 414.78512.46 ± 426.620.006
Vitamin D (ng/mL)
 Lumbar14.29 ± 10.5019.00 ± 13.4415.76 ± 11.680.185
 Total hip16.61 ± 10.7116.28 ± 11.3813.25 ± 14.030.59
 All16.80 ± 10.7416.11 ± 11.1313.25 ± 14.030.576
CTX (ng/mL)
 Lumbar2.50 ± 1.582.60 ± 1.461.85 ± 1.060.45
 Total hip2.41 ± 1.512.57 ± 1.552.38 ± 1.460.84
 All2.25 ± 1.362.71 ± 1.642.38 ± 1.460.43
bAP (ng/mL)
 Lumbar25.23 ± 27.2730.99 ± 30.2220.77 ± 9.410.54
 Total hip22.80 ± 25.9329.18 ± 30.2627.51 ± 22.180.67
 All19.48 ± 19.7331.33 ± 32.0827.51 ± 22.180.21
FGF 23 (pg/mL)
 Lumbar192.90 ± 242.32194.50 ± 229.21428.13 ± 275.640.039
 Total hip203.32 ± 203.32278.28 ± 278.28250.28 ± 250.280.731
 All185.37 ± 203.32229.46 ± 278.28240.43 ± 250.280.731
  1. HD Hemodialysis, PTH Parathyroid hormone, bAP bone alkaline phosphatase, CTX C-terminal telopeptide of type I collagen, FGF 23 Fibroblast growth factor 23
  2. Significant at p < 0.05 set in boldface